These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 18374589)

  • 21. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy.
    Yan H; Wang R; Zhao F; Zhu K; Jiang S; Zhao W; Feng R
    Acta Radiol; 2011 Jul; 52(6):646-50. PubMed ID: 21508201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size.
    Ulger S; Demirci NY; Eroglu FN; Cengiz HH; Tunc M; Tatci E; Yilmaz U; Cetin E; Avci E; Cengiz M
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):495-502. PubMed ID: 24474555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary tumor standardized uptake value (SUVmax) measured on
    Hui Z; Wei F; Ren H; Xu W; Ren X
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Limited prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage I & II) non-small cell lung cancer (NSCLC).
    Kim SJ; Kim YK; Kim IJ; Kim YD; Lee MK
    Radiother Oncol; 2011 Jan; 98(1):105-8. PubMed ID: 21159395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of Body Mass Index on the Prognostic Value of Tumor ¹⁸F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.
    Hyun SH; Lee KH; Choi JY; Kim BT; Kim J; Zo JI; Kim H; Kwon OJ; Ahn HK
    PLoS One; 2015; 10(12):e0145020. PubMed ID: 26684001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUVmax during 18FDG-PET scanning in small cell lung cancer: similar information as in non-small cell lung cancer?
    van der Leest C; Smit EF; Baas J; Versteijlen RJ; van Walree N; Hoogsteden HC; Aerts JG
    Lung Cancer; 2012 Apr; 76(1):67-71. PubMed ID: 21996089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.
    Zaizen Y; Azuma K; Kurata S; Sadashima E; Hattori S; Sasada T; Imamura Y; Kaida H; Kawahara A; Kinoshita T; Ishibashi M; Hoshino T
    Eur J Radiol; 2012 Dec; 81(12):4179-84. PubMed ID: 22884163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of pre-operative glucose-corrected maximum standardized uptake value in patients with non-small cell lung cancer after complete surgical resection and 5-year follow-up.
    Konings R; van Gool MH; Bard MP; Zwijnenburg A; Titulaer BM; Aukema TS; Valdés Olmos RA; Sikorska K; Klomp HM; Rijna H
    Ann Nucl Med; 2016 Jun; 30(5):362-8. PubMed ID: 26961089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapy.
    Zhao K; Wang C; Shi F; Huang Y; Ma L; Li M; Song Y
    BMC Cancer; 2021 Jan; 21(1):66. PubMed ID: 33446134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of prognostic values of primary tumor and nodal
    Lim CH; Hyun SH; Moon SH; Cho YS; Choi JY; Lee KH
    Eur Radiol; 2019 Oct; 29(10):5288-5297. PubMed ID: 30899978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of pre-treatment
    Aktan M; Koc M; Kanyilmaz G; Yavuz BB
    Ann Nucl Med; 2017 Jul; 31(6):462-468. PubMed ID: 28516335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma.
    Shimizu K; Maeda A; Yukawa T; Nojima Y; Saisho S; Okita R; Nakata M
    World J Surg Oncol; 2014 Nov; 12():343. PubMed ID: 25392182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of Independent Prognostic Value of Asphericity of
    Rogasch JMM; Furth C; Chibolela C; Hofheinz F; Ochsenreither S; Rückert JC; Neudecker J; Böhmer D; von Laffert M; Amthauer H; Frost N
    Clin Lung Cancer; 2020 May; 21(3):264-272.e6. PubMed ID: 31839531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment maximum standardized uptake value on 18F-fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non-small cell lung cancer after stereotactic body radiotherapy.
    Tanaka H; Hayashi S; Hoshi H
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e113-7. PubMed ID: 24176011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prognostic significance of the 18F-fluorodeoxyglucose positron emission tomography/computed tomography in early-stage nonsmall cell lung cancer.
    Geredeli C; Artac M; Kocak I; Koral L; Sakin A; Altinok T; Kaya B; Karaagac M
    J Cancer Res Ther; 2020; 16(4):816-821. PubMed ID: 32930124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Significance of Positron Emission Tomography in Subcentimeter Non-Small Cell Lung Cancer.
    Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
    Ann Thorac Surg; 2017 May; 103(5):1614-1620. PubMed ID: 27964917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of FDG uptake in primary inoperable non-small cell lung cancer.
    Tong AN; Han SR; Yan P; Gong H; Zhao H; Yao H; Wang YM
    Med Oncol; 2014 Jan; 31(1):780. PubMed ID: 24326983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between pretreatment FDG uptake and local control after stereotactic body radiotherapy in stage I non-small-cell lung cancer: the preliminary results.
    Hamamoto Y; Sugawara Y; Inoue T; Kataoka M; Ochi T; Takahashi T; Sakai S
    Jpn J Clin Oncol; 2011 Apr; 41(4):543-7. PubMed ID: 21262874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
    Hoang JK; Hoagland LF; Coleman RE; Coan AD; Herndon JE; Patz EF
    J Clin Oncol; 2008 Mar; 26(9):1459-64. PubMed ID: 18349396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of the Role of PET/CT SUVmax in Prognosis and Its Correlation with 
Clinicopathological Characteristics in Resectable Lung Squamous Cell Carcinoma].
    Ren H; Xu W; You J; Song X; Huang H; Zhao N; Ren X; Zhang X
    Zhongguo Fei Ai Za Zhi; 2016 Apr; 19(4):192-9. PubMed ID: 27118646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.